World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
61
Citations
12618
World Ranking
3011
National Ranking
1198

Overview

Neil Parkin is affiliated with Data First Consulting in the United States and has contributed to research primarily in the fields of Medicine and Engineering. Their work is particularly focused within several subfields, including Infectious Diseases, Virology, Electrical and Electronic Engineering, Epidemiology, and Hepatology.

The research topics covered by Neil Parkin center around HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV/AIDS Research and Interventions, as well as Hepatitis B and C virus studies. Additionally, they have engaged in areas related to Optical Network Technologies and Advanced Photonic Communication Systems.

Neil Parkin has published in various scientific venues. The most frequent publication venues include:

  • Viruses
  • UNC Libraries
  • Scientific Reports
  • Journal of Viral Hepatitis
  • Conference on Lasers and Electro-Optics

Recent research papers by Neil Parkin include:

  • Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations, 2020, Viruses
  • Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis, 2020, The Journal of Infectious Diseases
  • Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds, 2020, Viruses
  • Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing, 2020, Scientific Reports
  • Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping, 2020, Viruses

Neil Parkin has collaborated frequently with several researchers, including:

  • Robert W. Shafer
  • Hezhao Ji
  • Santiago Ávila-Ríos
  • Rami Kantor
  • Soo-Yon Rhee

Best Publications

  • A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

    Christos J. Petropoulos;Neil T. Parkin;Kay L. Limoli;Yolanda S. Lie

  • HIV-1 drug resistance in newly infected individuals.

    Daniel Boden;Arlene Hurley;Linqi Zhang;Yunzhen Cao

  • HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

    Ravindra K Gupta;John Gregson;Neil Parkin;Hiwot Haile-Selassie

  • Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

    Joris Hemelaar;Ramyiadarsini Elangovan;Jason Yun;Leslie Dickson-Tetteh

  • Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.

    David R Bangsberg;Edward P Acosta;Reena Gupta;David Guzman

  • Hepatitis C virus drug resistance–associated substitutions: State of the art summary

    Erik Lontok;Patrick Harrington;Anita Howe;Tara Kieffer

  • The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.

    Mina C. Hosseinipour;Joep J.G. van Oosterhout;Ralf Weigel;Sam Phiri

  • Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates.

    Jeannette M. Whitcomb;Neil T. Parkin;Colombe Chappey;Nicholas S. Hellmann

  • Evidence for Positive Epistasis in HIV-1

    Sebastian Bonhoeffer;Colombe Chappey;Neil T. Parkin;Jeanette M. Whitcomb

  • Persistence of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection

    Susan J. Little;Simon D. W. Frost;Joseph K. Wong;Davey M. Smith

  • Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials

    Evguenia S. Svarovskaia;Hadas Dvory-Sobol;Neil Parkin;Christy Hebner

  • Novel Four-Drug Salvage Treatment Regimens after Failure of a Human Immunodeficiency Virus Type 1 Protease Inhibitor-Containing Regimen: Antiviral Activity and Correlation of Baseline Phenotypic Drug Susceptibility with Virologic Outcome

    Steven G. Deeks;Nicholas S. Hellmann;Robert M. Grant;Neil T. Parkin

  • An RNA pseudoknot and an optimal heptameric shift site are required for highly efficient ribosomal frameshifting on a retroviral messenger RNA

    Mario Chamorro;Neil Parkin;Harold E. Varmus

  • Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product

    Sophie Roy;Michael G. Katze;Neil T. Parkin;Isaac Edery

  • Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In Vitro

    Michael F. Maguire;Rosario Guinea;Philip Griffin;Sarah Macmanus

  • Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation.

    N T Parkin;E A Cohen;A Darveau;C Rosen

  • Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations

    Wei Huang;Susan H. Eshleman;Jonathan Toma;Signe Fransen

  • Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report.

    Martin Markowitz;Hiroshi Mohri;Saurabh Mehandru;Anita Shet

  • Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo.

    N T Parkin;M Chamorro;H E Varmus

  • Identification of I50L as the Signature Atazanavir (ATV)-Resistance Mutation in Treatment-Naive HIV-1-Infected Patients Receiving ATV-Containing Regimens

    Richard Colonno;Ronald Rose;Colin McLaren;Alexandra Thiry

Frequent Co-Authors

Christos J. Petropoulos
Christos J. Petropoulos LabCorp (United States)
Silvia Bertagnolio
Silvia Bertagnolio World Health Organization
Susan H. Eshleman
Susan H. Eshleman Johns Hopkins University School of Medicine
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Roger Paredes
Roger Paredes University of Vic - Central University of Catalonia
J. Brooks Jackson
J. Brooks Jackson University of Iowa Hospitals and Clinics
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Robert W. Shafer
Robert W. Shafer Stanford University
Soo-Yon Rhee
Soo-Yon Rhee Stanford University
Jonathan M. Schapiro
Jonathan M. Schapiro Sheba Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology can open doors to various related fields and career paths, many of which offer flexible online degree options. For those interested in healthcare, several medical degrees online provide valuable credentials without the need to attend traditional campuses.

Public health is another key area linked to microbiology. Accredited programs offering an accredited online mph programs easy to get into allow students to gain important knowledge to tackle health issues from a broader perspective.

Careers in childhood development and support also intersect with microbiology, especially within healthcare settings. Understanding the role of a child life specialists salary can help prospective students evaluate this rewarding pathway, which often requires specialized certification.

For individuals with unique backgrounds, such as a criminal record, it’s encouraging to know that education remains accessible. Finding what is the best degree for a convicted felon can guide learners toward degrees that enhance employment prospects while accommodating their circumstances.

Best Scientists Citing Neil Parkin

Trending Scientists

Recently Published Articles